Sequential Use of Deferiprone and Desferrioxamine in Primary School Children with Thalassaemia major in Turkey

Publisher： Karger

E-ISSN： 1421-9662|102|1|17-21

ISSN： 0001-5792

Source： Acta Haematologica, Vol.102, Iss.1, 1999-09, pp. : 17-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors Influencing Effectiveness of Deferiprone in a Thalassaemia major Clinical Setting

By  

Acta Haematologica, Vol. 104, Iss. 2-3, 2001-01 ,pp. : 99-102

Karger

Access to resources Recommend Favorite

Effects of Deferiprone on Immune Status and Cytokine Pattern in Thalassaemia major

By  

Acta Haematologica, Vol. 108, Iss. 3, 2002-09 ,pp. : 144-149

Karger

Access to resources Recommend Favorite

Five-Year Trial of Deferiprone Chelation Therapy in Thalassaemia major Patients

By  

Acta Haematologica, Vol. 112, Iss. 4, 2004-11 ,pp. : 179-183

Karger

Access to resources Recommend Favorite

Safety Profile of Oral Iron Chelator Deferiprone in Chinese Children with Transfusion-Dependent Thalassaemia

By  

Current Drug Safety, Vol. 11, Iss. 2, 2016-04 ,pp. : 137-144

Bentham Science Publishers

Access to resources Recommend Favorite

Combined Chelation Therapy with Daily Oral Deferiprone and Twice-Weekly Subcutaneous Infusion of Desferrioxamine in Children with β-Thalassemia: 3-Year Experience

By  

Acta Haematologica, Vol. 133, Iss. 2, 2014-11 ,pp. : 226-236

Karger

Access to resources Recommend Favorite